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ogy. This is illustrated by the technological drive towardMicrobe Manufacturers
the single electron transistor and in the use of semicon-of Semiconductors ductor nanoparticles for bioimaging. It is well known
that the properties of semiconductors change as a func-
tion of size, shape, and crystallinity. Cadmium sulfide
(CdS) is a semiconductor material that has been used
Synthesis of cadmium sulfide (CdS) semiconductor for such applications as fluorescent labels and optoelec-
nanoparticles within a prokaryotic organism is re- tronic transistor components, where particles of approx-
ported for the first time by Sweeney et al. [1]. This imately 4–5 nm in diameter behave as so-called quantum
paper demonstrates the utility of microorganisms to dots (QD) [2, 3]. These particles when embedded within
perform chemistries outside the scope of their “nor- an appropriate matrix act as potential wells that confine
mal” metabolism and offers an environmentally benign and stabilize electrons in discrete energy levels. The
synthesis of CdS nanoparticles. technologically useful properties of CdS QDs are due
in part to the fact that the band-gap is tunable over a
Semiconductor nanoparticles are an extremely impor- range of 1.5–3.5 eV (i.e., visible to UV).
tant class of materials with properties that can be finely Many synthetic routes to semiconductor nanopar-
ticles involve highly toxic solvents, explosive precur-tuned through composition, size, and particle morphol-
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sors, high temperatures (250C–230C), and anoxic bioremediation has led to the characterization of cad-
mium-resistant organisms (both prokaryotic and euka-conditions [4–6]. Although methods that utilize less haz-
ardous precursors can also be used, these methods still ryotic). Investigations into the molecular and genetic
factors responsible for heavy metal tolerance have un-require high temperatures [4]. An advantage of current
synthetic methods for the production of CdS nanopar- covered some interesting pieces of the puzzle, but the
entire story varies in different organisms and there is aticles is the ability to control particle morphology by
varying conditions. Tunable synthesis results in mono- lot of work to be done in this field. The importance of
unraveling the complex set of events leading to CdSdisperse CdS nanoparticle populations of particular
shape (dots, rods, tetrapods), size (2–25 nm), and lumi- nanoparticle formation in bacteria, yeast, and plants
reaches beyond the immediate goals of nanotechnolo-nescent properties [7]. Using mild biomimetic synthetic
conditions, CdS, ZnS, CdSe, and ZnSe nanoparticles gists to produce CdS nanoparticles in a cost-effective
manner. These organisms have great potential for effec-have also been synthesized using biological molecules
as templates, including fatty acids, polyphosphates, tive bioremediation of cadmium-contaminated sites,
particularly those associated with mining.amino acids, and small thiol-containing glutathione-like
peptides [1, 7, 8]. In addition, supramolecular protein Metals such as Mn2, Co2, and Zn2 enter Gram-
negative bacteria (including E. coli), archaea, and yeastassemblies including viral protein capsids have served
as nanometer-scale templates for directed synthesis of cells through fast metal inorganic transport (MIT) sys-
tems [12]. These pathways are nonspecific, and thus itCdS [10, 11]. In many of these syntheses, the size and
crystallinity of the QD is determined by the biotemplate is probable that Cd2 enters microorganisms via MIT
systems [12]. Bacteria usually deal with cadmium toxic-as the CdS (or other) nanoparticles nucleate and grow.
Biosynthesis of CdS nanometer-sized crystallites has ity through elimination via efflux pumps, whereas yeasts
usually sequester cadmium in nanocrystals [8, 12]. Se-been described previously in eukaryotes, where two
yeast species, Candida glabrata and Schizosaccharo- questration is a more “energy expensive” process re-
quiring 16 molecules of ATP (adenosine triphosphate) inmyces pombe, produced CdS nanoparticles when cul-
tured in the presence of cadmium salts [8, 9]. order to generate one sulfide (from reduction of sulfate)
which complexes one cadmium. While sequestrationIn this issue of Chemistry & Biology, Sweeney et al.
[1] present the first CdS nanocrystals synthesized within may involve a large energy expenditure, efflux systems
require only about one ATP for every one Cd2 effluxeda prokaryotic organism. This “green chemistry,” micro-
bial culture approach, demonstrated within Escherichia [12]. Energetic expenses are more crucial when cells
are growing quickly or exponentially, as they are in logcoli, is strikingly different from current synthetic ap-
proaches to the synthesis of semiconductor nanopar- phase growth of E. coli. Consistent with this analysis,
Sweeney et al. [1] only observed significant CdS nano-ticles. Bacteria were grown in rich medium, at 37C,
supplemented with CdCl2 and Na2S prior to isolation particle formation during stationary growth phase (when
E. coli are replicating at a much slower rate). However,and characterization of the intracellularly produced CdS
nanoparticles. The CdS nanoparticles produced within this energetic argument must be tempered by the fact
that in these experiments the E. coli are provided withE. coli bacteria range in diameter from 2–5 nm. Although
moderately polydisperse, it is estimated that each bac- sulfide directly, perhaps bypassing normal metabolic
requirements for sulfide production. It might be possibleterium generated greater than 10,000 CdS nanopar-
ticles! In this work, the capability of biological systems that the two E. coli strains that form CdS nanoparticles
are deficient in proteins required for Cd2 efflux. On thefor materials synthesis was harnessed prior to under-
standing how the organisms control CdS crystal forma- other hand, these strains of E. coli may have acquired
the genes encoding proteins necessary to sequestertion. The genetic, and in turn biochemical, basis of CdS
formation within E. coli is currently being investigated. cadmium. Definitely, further genetic analysis of these
strains will prove to be very interesting.Interestingly, only two of the four E. coli strains tested
produced CdS nanoparticles. Having bacterial strains As mentioned by Sweeney et al. [1], glutathione (a
tripeptide consisting of cysteine, glutamic acid, and gly-with different phenotypes will prove useful in the investi-
gation into the mechanism behind CdS biosynthesis. cine) has been shown to be important for cadmium toler-
ance in organisms including yeast, plants, and animalsE. coli genetics are well understood; genes can be easily
replaced, overexpressed, and/or introduced utilizing [13]. For example, phytochelatins are composed of glu-
tathione-like peptide repeats and are known to bind androutine molecular biological methodologies. Therefore,
elucidation of the mechanism of CdS nanoparticle for- sequester heavy metals including Cd2. While Sweeney
et al. did find an increased thiol concentration in station-mation in E. coli might enable researchers to “genetically
tune” properties, including size, shape, and crystal ary phase cultures (correlating with abundant CdS nano-
particles), they did not find differences in thiol contentstructure, to match the technological requirements for
these materials. between the E. coli strains that do and do not produce
CdS nanoparticles. In order to investigate other cellularOne approach to understanding the role of the E. coli
genes and proteins involved in CdS nanoparticle forma- components that may be important to CdS nanoparticle
formation within E. coli, the authors visualized nanopar-tion is to look for E. coli homologs of particular genes
known to be important to the processes of heavy metal ticles within bacterial cells embedded in resin (60 nm
slices) by transmission electron microscopy (TEM). En-uptake, efflux, and sequestration in other microorgan-
isms [12]. While some organisms tolerate cadmium in ergy dispersive spectroscopy (EDS) was used for ele-
mental analysis of areas around CdS nanoparticles. Thistheir environment, no organisms known to date require
cadmium for life, and most organisms (including hu- analysis showed colocalization of phosphorus, nitrogen,
iron, and oxygen, possibly implicating phosphates inmans) are sensitive to its toxic effects. Previous research
in the fields of plant physiology, microbial ecology, and the mechanism of CdS mineralization.
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that the molecules must interact with only a minimalFinding Their Groove: Bifunctional
number of binding sites within the genome in order toMolecules Arrest Growth avoid affecting numerous biological processes. The
most common approach taken to develop transcrip-of Cancer Cells
tional inhibitors relies upon designing a molecule to tar-
get a specific DNA binding site associated with the gene
of interest. The designed molecule is then tested first
In this issue, Dickinson et al. describe an exciting ad- in vitro and subsequently in cell culture. However, it is
vance in the search for inhibitors of transcription that often difficult to predict the behavior of the molecule in
function well in cells [1]. The authors screen for small the complex environment of the cell based upon in vitro
molecules that selectively damage DNA and identify results due to issues of cell and nuclear permeability as
a histone gene as a potential new target for cancer well as the accessibility of the cognate DNA binding
therapeutic development. sites in the context of chromatin.
The approach taken by Gottesfeld and Dervan in this
issue of Chemistry & Biology circumvents some of theMany human diseases exhibit altered patterns of gene
difficulties outlined above and represents a departuretranscription [2–4]. Overexpression of the human tran-
from the typical mechanism of transcriptional inhibitorscriptional inhibitor Mdm2, for example, has been corre-
discovery [1]. Instead, the authors synthesized a smalllated with a number of human cancers [5–7]. These al-
group of molecules and screened for activity in humantered patterns are a signature of a particular disease,
colon cancer cells before investigating the origin of thethey are useful for characterization and diagnosis, and
observed effects. The molecules themselves are bifunc-they further offer an opportunity for targeting therapies
tional, containing a sequence-specific DNA bindingspecifically to diseased cells. One exciting approach is
module and a functional group that damages DNA (Fig-to home in on the affected genes themselves and inter-
ure 1). The DNA binding module is a hairpin polyamide,rupt or promote their transcription by using molecules
a minor groove binding agent composed largely of het-that interact with specific DNA sequences [8–11]. So, for
erocyclic amino acids that mediate sequence-specificexample, a triplex-forming oligonucleotide that prevents
interactions with the functional groups present in thethe transcription factor Sp1 from binding to DNA effec-
minor groove. The mode of binding for hairpin polyam-tively inhibits the transcription of the Src1 gene regu-
ides is such that pairs of heterocycles bind side-by-sidelated by that protein in cell culture [12]. Among the his-
in the minor groove recognizing a specific base pair intoric difficulties with identifying small molecules that can
a predictable manner—G•C versus C•G, for example—accomplish this task is that such molecules must not
and it is thus possible to design a structure that recognizesonly be cell and nuclear permeable but also must com-
a particular sequence. The authors prepared five polyam-pete for DNA binding sites with a wide range of proteins
in order to exert their function. An additional hurdle is ide-based structures for screening, each with a distinct
